Search research articles
Contact Us
Filters
Showing results (1181-1190 of 1,873) with videos related to
Page
of 188
Sort By:
European Journal of Heart Failure
|
May 15, 2026
Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trial
Brendon L Neuen, Henri Lu, Muthiah Vaduganathan, et al.
Diabetes, Obesity & Metabolism
|
October 30, 2015
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial
H J L Heerspink, T Ninomiya, F Persson, et al.
European Journal of Heart Failure
|
June 7, 2017
Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study
Gerasimos Filippatos, Aldo P Maggioni, Carolyn S P Lam, et al.
European Journal of Heart Failure
|
October 28, 2022
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials
João Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
European Journal of Heart Failure
|
January 19, 2013
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)
John J V McMurray, Inder S Anand, Rafael Diaz, et al.
JACC. Heart Failure
|
September 8, 2014
Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities)
Deepak K Gupta, Hicham Skali, Brian Claggett, et al.
Cardiovascular Diabetology
|
June 18, 2022
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
Magnus O Wijkman, Brian Claggett, Muthiah Vaduganathan, et al.
Circulation. Heart Failure
|
March 16, 2019
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status
Søren L Kristensen, Ulrik M Mogensen, Pardeep S Jhund, et al.
The New England Journal of Medicine
|
November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Hans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
European Journal of Neurology
|
November 21, 2024
Association of left atrial function with vascular brain injury: The Atherosclerosis Risk in Communities study
Wendy Wang, Pamela L Lutsey, Riccardo M Inciardi, et al.
Page
of 188
Search research articles
Search
Showing results (1181-1190 of 1,873) with videos related to
Sort By:
Page
of 188
European Journal of Heart Failure
|
May 15, 2026
Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trial
Brendon L Neuen, Henri Lu, Muthiah Vaduganathan, et al.
Diabetes, Obesity & Metabolism
|
October 30, 2015
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial
H J L Heerspink, T Ninomiya, F Persson, et al.
European Journal of Heart Failure
|
June 7, 2017
Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study
Gerasimos Filippatos, Aldo P Maggioni, Carolyn S P Lam, et al.
European Journal of Heart Failure
|
October 28, 2022
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials
João Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
European Journal of Heart Failure
|
January 19, 2013
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)
John J V McMurray, Inder S Anand, Rafael Diaz, et al.
JACC. Heart Failure
|
September 8, 2014
Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities)
Deepak K Gupta, Hicham Skali, Brian Claggett, et al.
Cardiovascular Diabetology
|
June 18, 2022
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
Magnus O Wijkman, Brian Claggett, Muthiah Vaduganathan, et al.
Circulation. Heart Failure
|
March 16, 2019
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status
Søren L Kristensen, Ulrik M Mogensen, Pardeep S Jhund, et al.
The New England Journal of Medicine
|
November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Hans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
European Journal of Neurology
|
November 21, 2024
Association of left atrial function with vascular brain injury: The Atherosclerosis Risk in Communities study
Wendy Wang, Pamela L Lutsey, Riccardo M Inciardi, et al.
Page
of 188